Jean-Jacques Mourad: Cohort Study Insights on Aspirin Use in Patients with Horton’s Disease
Jean-Jacques Mourad, Head of Internal Medicine at Franco-British Hospital, shared a post on LinkedIn about a recent article by Maxime Beydon, published in JAMA Network Open, adding:
“When well-constructed and properly analyzed cohort studies provide answers to the gray areas left by randomized trials…
All my sincere congratulations to the French authors of this work, which allows us to weigh a little more clearly the pros and cons of aspirin in patients treated for a Horton’s.”
Title: Low-Dose Aspirin for Cardiovascular Disease Primary Prevention in Patients With Giant Cell Arteritis
Authors: Maxime Beydon, David Hajage, Alexis F. Guédon, Fabrice Carrat, Raphaèle Seror, Florence Tubach
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 2, 2026, 10:35Dawn Carter: What Does an Acute Stroke Diagnosis Tell Us, If It Never Shows Up in Hospital Data?
-
Jun 2, 2026, 10:19Wolfgang Miesbach: Attitudes Towards Gene Therapy for Severe Haemophilia in Germany
-
Jun 1, 2026, 18:51Francesco Giurazza: New Publication on Glubran-2 in Acute Bleeding Patients with Coagulopathies
-
Jun 1, 2026, 18:50Donald Arnold is the Recipient of the Roberts Award – ISTH
-
Jun 1, 2026, 18:49Amirreza Jabbaripour Sarmadian: My First Paper as Corresponding Author on Upper Extremity DVT Following COVID-19 Vaccination
-
Jun 1, 2026, 18:49James P. Crowley: How Combining Vitamin D analogs with Chemotherapy Impacts Survival Outcomes
-
Jun 1, 2026, 18:42Debojyoti Chakraborty: Small But Meaningful Steps Toward A Gene Editing Trial For Sickle Cell Disease In India
-
Jun 1, 2026, 17:14Tiffany Gacel: What an Incredible Day With NBCA and The Red Bus Tour at Memorial at Gulfport?
-
Jun 1, 2026, 17:12Marie-Claire Kofi: Poster Highlights the Process of Establishing the Sickle Cell Transitions Policy Lab